The choice of pathogenetic therapy for a patient with dorsalgia: A review

Abstract

Musculoskeletal pain syndromes are one of the common causes of temporary disability associated with a decrease in the quality of life of patients. Dorsalgia (DA) is the most common form of these syndromes. Currently, osteoarthritis of the facet joints has been replaced as one of the main mechanisms for the occurrence of DA. The article discusses the main causes of DA development, important inflammatory processes in its symptoms. The issues of treatment of patients with DA are discussed. Information about the efficacy and safety of the use of Nise® (nimesulide) is given.